Paper17220161
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Rydén L and 49 others. Eur Heart J, 2007. Cited by 1,161 papers, by iCite.
Cite this record
ConductScience Library. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Papers, record 17220161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17220161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Artery Disease | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Angiopathies | Major topic |
| Angioplasty, Balloon, Coronary | |
| Arrhythmias, Cardiac | |
| Blood Glucose | |
| Death, Sudden, Cardiac | |
| Disease Progression | |
| Exercise Therapy | |
| Fibrinolytic Agents | |
| Heart Failure | |
| Homeostasis | |
| Humans | |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
| Hyperlipidemias | |
| Hypertension | |
| Myocardial Revascularization | |
| Risk Assessment | |
| Risk Factors | |
| Sex Factors | |
| Stroke |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17493946 | Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes. | https://conductscience.org/library/papers/17493946 |
Source PubMed
Cited by436
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42175474 | Epidemiological characteristics of serum small dense low-density lipoprotein cholesterol: From 2017 to 2019 in Chengdu adults, China. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42175474 | PubMed |
| 42133928 | Estimation of the Attributable Fraction of Noncommunicable Diseases Related to Physical Inactivity, Morocco. | Prev Chronic Dis | 2026 | https://conductscience.org/library/papers/42133928 | PubMed |
| 41849133 | Lipoprotein(a) in Essential Hypertension: Associations with Blood Pressure and Hypertension-Mediated Organ Damage. | High Blood Press Cardiovasc Prev | 2026 | https://conductscience.org/library/papers/41849133 | PubMed |
| 41849130 | Hypertension Treatment with Angiotensin Receptor Blockers and Other Antihypertensive Agents: A Real-World Registry from a High-Volume Specialized Center Over TwoDecades. | High Blood Press Cardiovasc Prev | 2026 | https://conductscience.org/library/papers/41849130 | PubMed |
| 41776566 | Prognostic stratification of cardiovascular risk and cardiac remodeling in prediabetes: a multimodal analysis comparing ADA and WHO/IEC diagnostic criteria. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41776566 | PubMed |
| 40445525 | Yinling Qushi Granule as a therapeutic agent for metabolic syndrome: pharmacological, molecular targets, and pharmacokinetic insights. | Adv Biotechnol (Singap) | 2025 | https://conductscience.org/library/papers/40445525 | PubMed |
| 40291506 | Investigating the obesity trend of overweight and obese people with pictograms among Iranian adults. | J Diabetes Metab Disord | 2025 | https://conductscience.org/library/papers/40291506 | PubMed |
| 40163115 | Combination of Glucagon-Like Peptide 1 Receptor Agonist and Thiazolidinedione for Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40163115 | PubMed |
| 40065410 | The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction. | Biol Direct | 2025 | https://conductscience.org/library/papers/40065410 | PubMed |
| 39827106 | Diabetes mellitus risk in post-myocardial infarction patients: FINDRISC versus self-assessment-a cross sectional study. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/39827106 | PubMed |
| 39596174 | Investigating the Effects of Gossypetin on Cardiovascular Function in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596174 | PubMed |
| 39583639 | Cardiodiabesity: Epidemiology, resource and economic impact. | Am J Prev Cardiol | 2024 | https://conductscience.org/library/papers/39583639 | PubMed |
| 38831442 | Milk protein concentrate supplementation improved appetite, metabolic parameters, adipocytokines, and body composition in dieting women with obesity: a randomized controlled trial. | BMC Nutr | 2024 | https://conductscience.org/library/papers/38831442 | PubMed |
| 38732069 | Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732069 | PubMed |
| 38642311 | Metabolic risks remain a serious threat to cardiovascular disease: findings from the Global Burden of Disease Study 2019. | Intern Emerg Med | 2024 | https://conductscience.org/library/papers/38642311 | PubMed |
| 38449681 | Diabetes prediction model for unbalanced community follow-up data set based on optimal feature selection and scorecard. | Digit Health | 2024 | https://conductscience.org/library/papers/38449681 | PubMed |
| 38361808 | Prevalence of metabolically healthy obesity and healthy overweight and the associated factors in southern Iran: A population-based cross-sectional study. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/38361808 | PubMed |
| 37582494 | Clinical Outcomes of Bronchoscopic Cryotherapy for Central Airway Obstruction in Adults: An 11-Years' Experience of a Single Center. | J Korean Med Sci | 2023 | https://conductscience.org/library/papers/37582494 | PubMed |
| 37445647 | The Relationship between All-Cause Natural Mortality and Copy Number of Mitochondrial DNA in a 15-Year Follow-Up Study. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445647 | PubMed |
| 36901633 | Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/36901633 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17220161
GET https://conductscience.org/api/papers/v1/17220161/authors?page=2